Navigation Links
Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
Date:12/19/2007

and colleagues discovered that the molecules in question indeed self-assembled to form a potent and long-lasting therapeutic agent.

This proof-of-principal work was published in the journal Proceedings of the National Academy of Sciences (Vol. 100, No. 9, April 29, 2003). Intriguingly, the scientists reported that they were able to induce the self-assembly of the complex not only by combining the two substances in the test tube before administration, but also by injecting the two compounds separately into the bloodstream of a mouse, where the compounds found each other and self-assembled into the desired complex.

In both cases, the hybrid molecules had a profound effect on the size of tumors in mouse modelsXshrinking tumors of both Kaposi's sarcoma and colon cancer.

"We were able to show the chemically programmed complex had at least 1,000-fold increase in the therapeutic effect compared with the small molecule alone," said Barbas. "With that came the idea that is this too powerful an approach not to push into human studies."

By the time the study was published, Barbas and Lerner had founded CovX, a privately held company with offices in Dublin, Ireland, and San Diego, CA, to do just that.

Today, two of the hybrid compounds under development by CovX have completed preclinical work with promising results as anti-tumor agents and have been approved for testing in humans. The compound the company calls CVX-045 is currently finishing Phase I trials. CVX-060 is poised to enter Phase 1 trials this month. A third compound to treat diabetes is close behind. By the end of next year, four novel drugs should be in clinical testing. "The Pfizer acquisition will allow us to fully realize the potential of this approach. Within five years we hope to have more than a dozen new drugs in clinical testing," said Barbas

"It has been a dream of mine to develop drugs that make a difference," said Barbas. "I couldn't be more excit
'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Scripps scientists discover fluorescence in key marine creature
2. Scripps research team blocks bacterial communication system to prevent deadly staph infections
3. Scripps scientists develop new tests that identify lethal prion strains quickly and accurately
4. Research shows skeleton to be endocrine organ
5. Newly created cancer stem cells could aid breast cancer research
6. Dominant cholesterol-metabolism ideas challenged by new research
7. Researchers identify proteins involved in new neurodegenerative syndrome
8. Texas researchers and educators head for Antarctica
9. MGH researchers describe new way to identify, evolve novel enzymes
10. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
11. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...f ornamental stones has grown all over the world i...t to the aesthetics of natural stones in buildings...is, undoubtedly, the ornamental stone par excellen...ve architectural or sculptural works which constit...ritage. Despite this, nowadays we have a very limi...
(Date:5/9/2008)...sm of action of compound found to induce neurotran...ay lead researchers to develop potential novel the...ateral sclerosis, Huntingtons disease, epilepsy, s... RICHMOND, Va. (May 9, 2008) Virginia Commonweal...ntibiotic works to modulate the activity of a neur...
(Date:5/9/2008)...r has won a share of grants totalling over 1m to t...ve, Dr. Declan Bates, a senior lecturer in the Dep...ter, is co-recipient of 1,068,000 in the form of j...and Physical Sciences Research Council (EPSRC) and...ciences Research Council (BBSRC). , The grants a...
(Date:5/8/2008)...he genome (DNA) of humans and many other organisms... attention to discovering how the many thousands o...of living cells that can turn genes on and off -- ... techniques and tools. Scientists in the Optical M...d Laboratory at Florida State University, working ...
Breaking Biology News(10 mins):Development of new techniques to understand marble quality and durability 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 3Engineer to spearhead research into cell metabolism and medical injuries 2Magnet Lab researchers make observing cell functions easier 2Scientists Report Refinements to Brain Surgery 8992 1Scientists Report Refinements to Brain Surgery 8992 2Walk away menopausal anxiety stress and depression 8988 1Walk away menopausal anxiety stress and depression 8988 2HIV isolate from Kenya provides clues for vaccine design 1762 1Obesity linked to decreased seatbelt use 8982 1Obesity linked to decreased seatbelt use 8982 2
...cientists from the University of Delaware have mad...nucleic acids (RNAs), discovering 10 times more sm...had been identified. The advance is reported in th...h was conducted over the course of the last year a... Pamela J. Green, Crawford H. Greenewalt Endowed C...
...n the neural train wreck that is stroke, the cutof... acid, as well as by overexciting receptors on the...g the detailed mechanism of this excitotoxicity an...hain of molecular events contributes to its damage... Neuron, Jun Gao and colleagues say that their fin...
... compound isolated from a cyanobacterium, a type o...of becoming a natural drug candidate for fighting ...according to an in vitro study by researchers in S...at a potent agent against Alzheimer,s has been iso...scum., The study was published in the Dec. 26 issu...
...rostate cancer is a cruel disease. Left untreated,...d, to bone where they form fracture-prone tumors t... of men who die from prostate cancer die with meta... very little about how migrating prostate cancer c...e the dense bony lesions characteristic of prostat...
Other Biology News:Delaware scientists make significant advance in study of small RNAs 2Delaware scientists make significant advance in study of small RNAs 3Molecular cabal contributes to stroke damage 2Natural compound from 'pond scum' shows potential activity against Alzheimer's 2Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors 2Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors 3
(Date:5/9/2008)...nsed to Orcrist - Toronto Stock ...FirstCall/ - BioMS Medical Corp (TSX: MS),a leadi...s (MS), today,announced an update on its pipeline ...., The Company has entered into a Royalty and Ass...0, a technology based on hyaluronic acid that,has ...
(Date:5/9/2008)...ll/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:...n,patient enrolment in a clinical trial using intr...on with cyclophosphamide, a chemotherapeutic agent...anced cancers. The,Principal Investigators are Dr....ann de Bono and Dr. Kevin Harrington of The Royal ...
(Date:5/9/2008)...all/ -- Pulmo BioTech Inc. (OTC,Bulletin Board: PL...e in,PulmoScience Inc. by 10%, taking its total ho...Molecular Imaging Diagnostic Technique for pulmona... Garry McCann said, "We are confident the Molecula...Science, will dominate the,market for the diagnosi...
(Date:5/9/2008)...e-FirstCall/ -- InterMune, Inc.,(Nasdaq: ITMN ) t...,Executive Officer of InterMune, will present at t...Las Vegas on May 14, 2008 at 9:20 a.m. PDT (12:20,...presentation, investors and other,interested parti...terMune,s,corporate website at http://www.intermu...
Breaking Biology Technology:BioMS Medical Provides Update On Pipeline Products 2BioMS Medical Provides Update On Pipeline Products 3Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial 3Pulmo BioTech Announces an Increase in its Stake in PulmoScience 2Pulmo BioTech Announces an Increase in its Stake in PulmoScience 3
...based supply chain technology provider, reported F...ting , a George-based division of Cooper Industrie...kforce productivity. , ,The lighting manufacturer ...Prairie,s DLx Warehouse, slotting and workforce pe... slotting application will provide improved pickin...
...nc. , a Madison-based manufacturer of high-power d...nications markets, has been awarded $1.4 million i...y Diode Sources program, sponsored by the Defense...l goal of the project is to increase a laser,s pow...eat emitted from a laser during operation. Efficie...
...t of health care sector venture capital shows Wisc... half of 2005, but its position could shoot up as ... ,The report was compiled by BioEnterprise , a bu... specializing in the health care sector. , ,"Part ...r is we felt like a lot of the deals that were get...
...ays of summer. Business slows. Indeed, in Europe, ... entered a state of suspended animation that will ...he outdoors beckons. Families cry out for attentio... rare weekend away from e-mail, I returned to a Mo... that had miraculously grown between 8 p.m. Friday...
Other Biology Technology:Alfalight garners $1.4 million defense funding for diode program 2Wisconsin ranks low in mid-year health care capital investment report 2Wisconsin ranks low in mid-year health care capital investment report 3Leaving it all behind 2
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5
...Zeba Desalt Spin Columns contain a proprietary hig..., that offers exceptional desalting and protein-re...lly available resins. Samples containing as low as...ceptional protein recovery and > 95% retention of ...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587
Immunogen: Synthetic peptide corresponding to amino acids 22-37 SGHKSEEKREKMKRTL Antigen Family: Regulator of G-protein signalling; Antigen Subfamily: not assigned-Regulator of G-protein sig
Biology Products: